Trial intelligence / Profile preview

Pilot trial of triheptanoin for preventive treatment of migraine

2016-001019-19Phase 2Completed

Sponsor
Centre Hospitalier Universitaire de Liège
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of triheptanoin in migraine, sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Primary outcome measures. Started May 2016; status: completed.

02

Drugs

triheptanoin
03

Conditions

migraine

Beyond the preview

Go deeper on 2016-001019-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-001019-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call